Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Colorectal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05039944
What this trial is testing

SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies

Who this might be right for
Colorectal Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 7
Testing effectiveness (Phase 2)Study completedNCT00569699
What this trial is testing

Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)

Who this might be right for
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd. 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381309
What this trial is testing

Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM

Who this might be right for
CRCLiver Metastasis Colon Cancer
Jun Huang 114
Not applicableStudy completedNCT05468593
What this trial is testing

Patient Outcomes After Hepatic Artery Infusion Pump Placement

Who this might be right for
Colorectal Liver MetastasesColorectal Cancer
Mayo Clinic 12
Large-scale testing (Phase 3)Ended earlyNCT07152821
What this trial is testing

Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma

Who this might be right for
Colorectal Cancer
Canadian Cancer Trials Group 21
Testing effectiveness (Phase 2)Ended earlyNCT00816777
What this trial is testing

Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Unresectable Metastatic Colo-rectal Cancer
Generic Devices Consulting, Inc. 4
Not applicableLooking for participantsNCT04616495
What this trial is testing

Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases

Who this might be right for
Colorectal CancerMetastatic Liver CancerLiver Metastases
Hospital Universitario La Fe 30
Testing effectiveness (Phase 2)Study completedNCT02063529
What this trial is testing

FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 101
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Not Yet RecruitingNCT07025239
What this trial is testing

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)Study completedNCT00003834
What this trial is testing

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 44
Testing effectiveness (Phase 2)Study completedNCT04109924
What this trial is testing

TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colon AdenocarcinomaMetastatic Rectal Adenocarcinoma+24 more
Roswell Park Cancer Institute 42
Early research (Phase 1)Study completedNCT00089362
What this trial is testing

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT03965234
What this trial is testing

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Who this might be right for
Metastatic Bone SarcomaMetastatic Malignant Neoplasm in the LungMetastatic Soft Tissue Sarcoma+3 more
Roswell Park Cancer Institute 99
Large-scale testing (Phase 3)Study completedNCT02162563
What this trial is testing

Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases

Who this might be right for
Colorectal CancerLiver Metastases
Dutch Colorectal Cancer Group 530
Testing effectiveness (Phase 2)Study completedNCT00321828
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
NSABP Foundation Inc 90
Early research (Phase 1)Looking for participantsNCT06778863
What this trial is testing

CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor+8 more
Clasp Therapeutics, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT04513951
What this trial is testing

AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 62
Early research (Phase 1)Study completedNCT00138177
What this trial is testing

Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage III Colon Cancer+4 more
National Cancer Institute (NCI) 54
Not applicableUnknownNCT04525313
What this trial is testing

The Prediction Model of Avastin Plus Chemotherapy in Unresectable Ras Mutant CRLM Patients

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 116
Next Page